Metabolism – New Therapeutic Targets for Inflammatory Bowel Disease

Genetic studies conducted over the last 20 years have been hugely successful in identifying variation across the genome that is associated with disease risk. The inflammatory bowel diseases (IBD) Crohnʼs disease and ulcerative colitis have been exemplars of this success, with now > 250 individual genomic risk coordinates identified. This success sometimes overshadows the more humbling fact that mechanistic understanding is very scarce for how these genetic risk factors conspire with environmental triggers to cause disease. For some risk loci, we completely lack any understanding of the very basic function of their gene products.

Publikationsverlauf

Artikel online veröffentlicht:
17. November 2021

• References

• 1 Cader MZ, Boroviak K, Zhang Q. et al. C13orf31 (FAMIN) is a central regulator of immunometabolic function. Nat Immunol 2016; 17: 1046-1056
• 2 Cader MZ, Pereira de Almeida Rodrigues RP, West JA. et al. FAMIN is a multifunctional purine enzyme enabling the purine nucleotide cycle. Cell 2020; 180: 278-295.e23
• 3 Lowenstein J, Tornheim K. Ammonia production in muscle: the purine nucleotide cycle. Science 1971; 171: 397-400